Amplifon S.p.A.

WBAG:AMP Stock Report

Market Cap: €5.6b

Amplifon Past Earnings Performance

Past criteria checks 2/6

Amplifon has been growing earnings at an average annual rate of 12.1%, while the Healthcare industry saw earnings growing at 10.1% annually. Revenues have been growing at an average rate of 9.1% per year. Amplifon's return on equity is 13.9%, and it has net margins of 6.6%.

Key information

12.1%

Earnings growth rate

12.0%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate9.1%
Return on equity13.9%
Net Margin6.6%
Next Earnings Update06 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Amplifon makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

WBAG:AMP Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,360156160
30 Jun 242,324162160
31 Mar 242,293161160
31 Dec 232,260155160
30 Sep 232,224166120
30 Jun 232,196174120
31 Mar 232,164177120
31 Dec 222,119179120
30 Sep 222,108179110
30 Jun 222,053174110
31 Mar 222,015171110
31 Dec 211,948164110
30 Sep 211,84115590
30 Jun 211,82115990
31 Mar 211,56811490
31 Dec 201,5039790
30 Sep 201,54988100
30 Jun 201,51467100
31 Mar 201,70496100
31 Dec 191,732109100
30 Sep 191,624104750
30 Jun 191,535108750
31 Mar 191,445104750
31 Dec 181,362100750
30 Sep 181,327110710
30 Jun 181,302110710
31 Mar 181,279102710
31 Dec 171,266101710
30 Sep 171,23172600
30 Jun 171,21372600
31 Mar 171,17568600
31 Dec 161,13364600
30 Sep 161,10461550
30 Jun 161,07858550
31 Mar 161,05752550
31 Dec 151,03447550
30 Sep 151,00146490
30 Jun 1597542490
31 Mar 1593440490
31 Dec 1489146490
30 Sep 1486440-1440
30 Jun 1483531-810
31 Mar 1482625-170
31 Dec 1382713480

Quality Earnings: AMP has high quality earnings.

Growing Profit Margin: AMP's current net profit margins (6.6%) are lower than last year (7.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: AMP's earnings have grown by 12.1% per year over the past 5 years.

Accelerating Growth: AMP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: AMP had negative earnings growth (-6.4%) over the past year, making it difficult to compare to the Healthcare industry average (15.2%).

Return on Equity

High ROE: AMP's Return on Equity (13.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 08:20
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Amplifon S.p.A. is covered by 31 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Paola SagliettiBanca Akros S.p.A. (ESN)
Hassan Al-WakeelBarclays
Hugo SolvetBNP Paribas Exane